Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus

被引:1
|
作者
Nunez, A. [1 ]
Aguilera, V. [1 ]
Sanchez-Torrijos, Y. [1 ]
Sousa, J. M. [1 ,2 ]
Ferrer, M. T. [1 ,2 ]
Giraldez, A. [1 ,2 ]
Ampuero, J. [3 ,4 ]
Perez-Martinez, J. [1 ]
Cuaresma, M. [2 ,5 ]
Ruiz-Perez, R. [2 ,5 ]
Pascasio, J. M. [3 ,4 ]
机构
[1] Hosp Univ Virgen del Rocio, Digest Dis, Seville, Spain
[2] Hosp Univ Virgen del Rocio, IBIS, Seville, Spain
[3] Hosp Univ Virgen del Rocio, IBIS, Digest Dis, Seville, Spain
[4] Hosp Univ Virgen del Rocio, CIBERehd, Seville, Spain
[5] Hosp Univ Virgen del Rocio, FISEVI, Seville, Spain
关键词
D O I
10.1016/S0168-8278(17)31325-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-131
引用
收藏
页码:S469 / S469
页数:1
相关论文
共 50 条
  • [1] Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosis
    Mettke, F.
    Schlevogt, B.
    Deterding, K.
    Wranke, A.
    Port, K.
    Manns, M. P.
    Vogel, A.
    Cornberg, M.
    Wedemeyer, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S210 - S211
  • [2] High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
    Cardoso, Helder
    Vale, Ana
    Rodrigues, Susana
    Goncalves, Regina
    Albuquerque, Andreia
    Pereira, Pedro N.
    Lopes, Susana
    Silva, Marco
    Andrade, Patricia
    Morais, Rui
    Coelho, Rosa
    Macedo, Guilherme
    HEPATOLOGY, 2016, 64 : 663A - 663A
  • [3] High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
    Cardoso, Helder
    Vale, Ana Maria
    Rodrigues, Susana
    Goncalves, Regina
    Albuquerque, Andreia
    Pereira, Pedro
    Lopes, Susana
    Silva, Marco
    Andrade, Patricia
    Morais, Rui
    Coelho, Rosa
    Macedo, Guilherme
    JOURNAL OF HEPATOLOGY, 2016, 65 (05) : 1070 - 1071
  • [4] Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis
    Mettke, F.
    Schlevogt, B.
    Deterding, K.
    Wranke, A.
    Smith, A.
    Port, K.
    Manns, M. P.
    Vogel, A.
    Cornberg, M.
    Wedemeyer, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 516 - 525
  • [5] INTERFERON-FREE THERAPY IS NOT A TRIGGER FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC INFECTION WITH HEPATITIS C VIRUS
    Suceveanu, Andra-Iulia
    Stoian, Anca Pantea
    Mazilu, Laura
    Voinea, Felix
    Hainarosie, Razvan
    Diaconu, Camelia Cristina
    Pituru, Silviu
    Nitipir, Cornelia
    Badiu, Dumitru Cristinel
    Ceausu, Iuliana
    Suceveanu, Adrian Paul
    FARMACIA, 2018, 66 (05) : 904 - 908
  • [6] INTERFERON-FREE THERAPY OF CHRONIC HEPATITIS C LOWERS THE LONG-TERM RISK FOR DE NOVO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH LIVER CIRRHOSIS
    Mettke, Friederike
    Deterding, Katja
    Port, Kerstin
    Schlevogt, Bernhard
    Manns, Michael P.
    Maasoumy, Benjamin
    Cornberg, Markus
    Wedemeyer, Heiner
    HEPATOLOGY, 2019, 70 : 928A - 929A
  • [7] Interferon-Free Hepatitis C Virus Therapy
    Pawlotsky, Jean-Michel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (11): : 1 - 13
  • [8] Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus-Related Cirrhosis
    Singal, Ashwani K.
    Singh, Amanpal
    Jaganmohan, Sathya
    Guturu, Praveen
    Mummadi, Rajasekhara
    Ku, Yong-Fang
    Sood, Gagan K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (02) : 192 - 199
  • [9] Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
    Ismail, Mohamed Saleh
    Mohamed, Islam
    Polychronopoulou, Efstathia
    Goss, John A.
    Kuo, Yong-Fang
    Kanwal, Fasiha
    Jalal, Prasun K.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 701 - 711
  • [10] Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Luo, Jiing-Chyuan
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (04) : 357 - 368